HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qin Yang Selected Research

KRN 4884

7/2002Hypoxic preconditioning in coronary microarteries: role of EDHF and K+ channel openers.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qin Yang Research Topics

Disease

104Neoplasms (Cancer)
01/2022 - 02/2002
47Inflammation (Inflammations)
10/2022 - 03/2010
21Fibrosis (Cirrhosis)
01/2022 - 11/2004
20Breast Neoplasms (Breast Cancer)
05/2022 - 01/2014
20Infections
01/2022 - 06/2006
20Neoplasm Metastasis (Metastasis)
01/2022 - 07/2003
17Obesity
01/2022 - 07/2005
13Hypoxia (Hypoxemia)
06/2021 - 07/2002
12Carcinoma (Carcinomatosis)
09/2021 - 02/2002
11Type 2 Diabetes Mellitus (MODY)
01/2021 - 07/2005
11Insulin Resistance
01/2020 - 07/2005
10Ischemia
10/2022 - 01/2007
10Hepatocellular Carcinoma (Hepatoma)
01/2022 - 12/2014
10Carcinogenesis
06/2021 - 05/2003
9Acute Kidney Injury (Acute Renal Failure)
10/2022 - 01/2016
9Body Weight (Weight, Body)
01/2022 - 04/2007
8Myocardial Infarction
09/2022 - 12/2009
8Necrosis
04/2022 - 01/2013
8Coronary Artery Disease (Coronary Atherosclerosis)
12/2020 - 04/2007
7Uterine Cervical Neoplasms (Cancer of the Cervix)
01/2022 - 03/2012
7Hypertension (High Blood Pressure)
09/2021 - 01/2007
7Colorectal Neoplasms (Colorectal Cancer)
01/2021 - 09/2016
7Adenocarcinoma
03/2019 - 10/2012
7Cardiovascular Diseases (Cardiovascular Disease)
01/2019 - 04/2011
6Hyperlipidemias (Hyperlipidemia)
05/2022 - 01/2017
6Spasm (Spasms)
02/2022 - 12/2010
6Liver Diseases (Liver Disease)
12/2021 - 11/2004
6Pancreatic Neoplasms (Pancreatic Cancer)
01/2021 - 03/2006
6Stomach Neoplasms (Stomach Cancer)
01/2021 - 09/2017
6Stroke (Strokes)
08/2019 - 05/2014
6Epilepsy (Aura)
01/2018 - 05/2014
5Ischemic Stroke
12/2022 - 08/2010
5COVID-19
07/2022 - 01/2020
5Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
05/2022 - 11/2011
5Infarction (Infarctions)
05/2022 - 06/2010
5Triple Negative Breast Neoplasms
05/2022 - 01/2018
5Glucose Intolerance
01/2022 - 07/2005
5Wounds and Injuries (Trauma)
06/2021 - 11/2011
5Atrial Fibrillation
03/2021 - 01/2017
5Seizures (Absence Seizure)
01/2021 - 01/2017
5Sepsis (Septicemia)
01/2020 - 01/2019
5Atherosclerosis
11/2016 - 01/2007
5Hyperkalemia
10/2014 - 08/2002
4Acute Liver Failure (Fulminant Hepatic Failure)
07/2022 - 01/2020
4Reperfusion Injury
05/2022 - 12/2018
4Hypertrophy
03/2022 - 01/2016
4Periodontitis
02/2022 - 01/2020
4Alzheimer Disease (Alzheimer's Disease)
01/2022 - 11/2015
4Glioblastoma (Glioblastoma Multiforme)
11/2021 - 08/2006
4Liver Neoplasms (Liver Cancer)
10/2021 - 10/2019
4Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
08/2021 - 10/2012
4Diabetic Nephropathies (Diabetic Nephropathy)
01/2020 - 04/2007
4Weight Loss (Weight Reduction)
01/2020 - 01/2014
4Congenital Heart Defects (Congenital Heart Defect)
01/2020 - 04/2014
4Cholangitis
01/2020 - 10/2015

Drug/Important Bio-Agent (IBA)

48Proteins (Proteins, Gene)FDA Link
04/2022 - 05/2003
33Biomarkers (Surrogate Marker)IBA
10/2022 - 06/2010
15Pharmaceutical PreparationsIBA
07/2021 - 09/2008
14CytokinesIBA
09/2022 - 08/2007
14Glucose (Dextrose)FDA LinkGeneric
05/2022 - 01/2002
13Biological ProductsIBA
12/2022 - 02/2002
13Cisplatin (Platino)FDA LinkGeneric
10/2022 - 03/2013
13LipidsIBA
05/2022 - 11/2016
13CollagenIBA
02/2022 - 11/2004
13Messenger RNA (mRNA)IBA
05/2021 - 05/2007
11Long Noncoding RNAIBA
02/2022 - 01/2016
10DNA (Deoxyribonucleic Acid)IBA
05/2022 - 07/2009
10EnzymesIBA
01/2022 - 02/2002
9Therapeutic UsesIBA
07/2022 - 11/2004
9ResveratrolIBA
05/2022 - 12/2011
9MicroRNAs (MicroRNA)IBA
06/2021 - 10/2011
7Interleukin-6 (Interleukin 6)IBA
02/2022 - 01/2013
7Histones (Histone)IBA
01/2022 - 04/2014
7Insulin (Novolin)FDA Link
01/2022 - 07/2005
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
09/2020 - 04/2007
6Oxygen (Dioxygen)IBA
05/2022 - 11/2011
6Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2022 - 01/2012
6Phosphotransferases (Kinase)IBA
01/2022 - 11/2018
6AntigensIBA
02/2019 - 06/2006
6endothelium-dependent hyperpolarization factor (EDHF)IBA
01/2014 - 09/2002
5LipopolysaccharidesIBA
10/2022 - 02/2015
5HomocysteineIBA
03/2022 - 12/2013
5RNA (Ribonucleic Acid)IBA
01/2022 - 03/2012
5Peroxisome Proliferator-Activated Receptors (PPAR)IBA
02/2021 - 10/2018
5SolutionsIBA
09/2020 - 07/2003
5Blood Proteins (Serum Proteins)IBA
01/2020 - 01/2013
5Retinol-Binding Proteins (Retinoid Binding Proteins)IBA
01/2016 - 07/2005
4Fatty Acids (Saturated Fatty Acids)IBA
01/2022 - 02/2014
4Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
01/2022 - 10/2017
4Caspase 3 (Caspase-3)IBA
01/2022 - 12/2011
4Triglycerides (Triacylglycerol)IBA
01/2022 - 06/2006
4Small Interfering RNA (siRNA)IBA
12/2021 - 01/2016
4Alanine Transaminase (SGPT)IBA
01/2021 - 11/2004
4Sirolimus (Rapamycin)FDA Link
01/2021 - 05/2014
4Sirtuin 1IBA
01/2020 - 02/2014

Therapy/Procedure

49Therapeutics
12/2022 - 07/2003
13Drug Therapy (Chemotherapy)
07/2020 - 02/2002
7Coronary Artery Bypass (Coronary Artery Bypass Surgery)
02/2022 - 12/2010
5Transplantation
12/2022 - 12/2009
5Radiotherapy
01/2018 - 05/2014